Abstract:Abstract Purpose: We plan to use a tissue microarray-based microRNA(miRNA) detection by in situ hybridization with LNA probe and support vector machine on base of data mining to construct the Prognostic model for breast cancer and triple negative breast cancer (TNBC). Methods: Combining the BreastMark miRNA database and papers published, we chose candidate miRNAs. Then a tissue microarray-based miRNA detection in situ hybridization with LNA probe was used to detect miRNA expression in 445 breast cancer tissue. Univariate analysis with Kaplan-Meier identified independent prognostic factors, 445 patients was divided into the training set and validation set (70% VS 30%) by software R(version 3.2.3), then support vector machine on base of data mining was used to construct the Prognostic model for breast cancer and triple negative breast cancer via software R and predict.svm(e1071). Results: 15 miRNAs were detected from 445 breast cancer tissue and univariate analysis with Kaplan-Meier identified significant prognostic miRNAs: miR-361-5p, miR-301a, miR-223, miR-421, miR-454, miR-493 were the independent prognostic factors for DFS. By using data mining technique, we combined clinical factors(stage, tumor size, lymphnode status, molecular subtype) and miRNAs mentioned above to establish the personalized predictive mathematical models SVM-BC and SVM-TNBC. In the training set and validation set of SVM-BC model, the AUC value of ROC curve for DFS were 0.86,0.83. The total accuracy,sensitivity,specificity of SVM-BC model for DFS were 94%,73%,99% and 84%,57%,92% in the training set and validation set. The SVM-BC model can divide breast cancer patients into high-risk and low-risk groups, and 5-year survival rates for low-risk patients were higher than that for high-risk patients(96.8% VS 39.3%, p<0.001). In the training set and validation set of SVM-TNBC model, the AUC value of ROC curve for DFS were 0.84,0.86. The total accuracy,sensitivity,specificity of SVM-TNBC model for DFS were 90%,71%,97% and 84%,55%,94% in the training set and validation set. The SVM-TNBC model can divide breast cancer patients into high-risk and low-risk groups, and 5-year survival rates for low-risk patients were higher than that for high-risk patients(93.9 % VS 23.5%, p <0.001). Conclusion: The Prognostic model basing of tissue microarray-based miRNA detection in situ hybridization with LNA probe and support vector machine for prognosis can effectively predict the prognosis of breast cancer and TNBC. Citation Format: Cao Z, Yao L, Hu X, Zhang Z, Shao Z. In-situ hybridization of microRNA and support vector machines–based prognostic classifiers for breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-37.

The Prediction of Prognosis and Evaluation of Curative Effect for Breast Cancer Based on Support Vector Machine

A primary study for cancer prognosis based on classification and regression using support vector machine

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

A Gene Signature for Breast Cancer Prognosis Using Support Vector Machine

Prognosis prediction of human breast cancer by integrating deep neural network and support vector machine: Supervised feature extraction and classification for breast cancer prognosis prediction

Breast Cancer Prediction using KNN, SVM, Logistic Regression and Decision Tree

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

Classification Prediction of Breast Cancer Based on Machine Learning

Application and comparison of several machine learning methods in the prognosis of cervical cancer

The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study

Breast Cancer Surgery 10-Year Survival Prediction by Machine Learning: A Large Prospective Cohort Study

Abstract P2-05-37: In-situ Hybridization of Microrna and Support Vector Machines–based Prognostic Classifiers for Breast Cancer

Breast Cancer Prediction Based on Machine Learning

Combined Feature Selection and Cancer Prognosis Using Support Vector Machine Regression

Machine learning-based models for the prediction of breast cancer recurrence risk

Predicting factors for survival of breast cancer patients using machine learning techniques

Machine learning models in breast cancer survival prediction

Machine Learning Algorithms For Breast Cancer Prediction And Diagnosis

Machine learning-based prediction model for distant metastasis of breast cancer

Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning

Use of Peripheral Lymphocytes and Support Vector Machine for Survival Prediction in Breast Cancer Patients